Mirova’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.1M | Sell |
63,957
-9,318
| -13% | -$4.47M | 1.18% | 22 |
|
|
2026
Q1 | $36M | Buy |
73,275
+63,086
| +619% | +$34.2M | 1.46% | 18 |
|
|
2025
Q4 | $5.9M | Sell |
10,189
-9,779
| -49% | -$5.53M | 0.85% | 42 |
|
|
2025
Q3 | $9.68M | Sell |
19,968
-118,304
| -86% | -$55.1M | 1.37% | 20 |
|
|
2025
Q2 | $56.1M | Sell |
138,272
-13,179
| -9% | -$5.51M | 7.91% | 1 |
|
|
2025
Q1 | $75.4M | Sell |
151,451
-10,410
| -6% | -$5.64M | 13.56% | 1 |
|
|
2024
Q4 | $84.2M | Buy |
161,861
+2,390
| +1% | +$1.31M | 14.53% | 1 |
|
|
2024
Q3 | $98.6M | Sell |
159,471
-6,321
| -4% | -$3.74M | 17.05% | 1 |
|
|
2024
Q2 | $91.7M | Sell |
165,792
-49,229
| -23% | -$28.2M | 16.75% | 1 |
|
|
2024
Q1 | $125M | Buy |
215,021
+3,605
| +2% | +$2.02M | 22.14% | 1 |
|
|
2023
Q4 | $112M | Buy |
211,416
+1,012
| +0.5% | +$490K | 22.98% | 1 |
|
|
2023
Q3 | $107M | Sell |
210,404
-12,434
| -6% | -$6.63M | 21.44% | 1 |
|
|
2023
Q2 | $116M | Sell |
222,838
-43,642
| -16% | -$23.6M | 20.46% | 1 |
|
|
2023
Q1 | $154M | Sell |
266,480
-14,807
| -5% | -$8.35M | 22.15% | 1 |
|
|
2022
Q4 | $155M | Sell |
281,287
-10,748
| -4% | -$5.7M | 24.25% | 1 |
|
|
2022
Q3 | $148M | Sell |
292,035
-30,514
| -9% | -$17.1M | 24.92% | 1 |
|
|
2022
Q2 | $175M | Buy |
322,549
+257
| +0.1% | +$141K | 24.9% | 1 |
|
|
2022
Q1 | $190M | Sell |
322,292
-6,461
| -2% | -$3.71M | 25.48% | 1 |
|
|
2021
Q4 | $219M | Buy |
328,753
+6,037
| +2% | +$3.77M | 26.27% | 1 |
|
|
2021
Q3 | $184M | Sell |
322,716
-16,806
| -5% | -$9.22M | 23.73% | 1 |
|
|
2021
Q2 | $171M | Hold |
339,522
| – | – | 20.53% | 1 |
|
|
2021
Q1 | $155M | Buy |
339,522
+82,737
| +32% | +$39.5M | 18.48% | 1 |
|
|
2020
Q4 | $120M | Sell |
256,785
-10,175
| -4% | -$4.77M | 15.38% | 2 |
|
|
2020
Q3 | $118M | Buy |
266,960
+22,900
| +9% | +$9.46M | 18.97% | 1 |
|
|
2020
Q2 | $88.4M | Buy |
244,060
+11,587
| +5% | +$3.88M | 20.3% | 1 |
|
|
2020
Q1 | $65.9M | Buy |
232,473
+27,613
| +13% | +$8.71M | 24.95% | 1 |
|
|
2019
Q4 | $66.6M | Sell |
204,860
-167,543
| -45% | -$50.8M | 23.16% | 1 |
|
|
2019
Q3 | $108M | Sell |
372,403
-59,046
| -14% | -$16.9M | 13.37% | 1 |
|
|
2019
Q2 | $127M | Buy |
431,449
+301,038
| +231% | +$82.9M | 11.2% | 1 |
|
|
2019
Q1 | $35.7M | Sell |
130,411
-24,614
| -16% | -$6.13M | 19.35% | 1 |
|
|
2018
Q4 | $34.7M | Buy |
+155,025
| New | +$36.4M | 15.86% | 1 |
|
Other funds holding TMO
Mirova's TMO Position: Q2 2026 in Review
Mirova reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, selling an estimated $4.47M and leaving 63,957 shares worth $32.1M. The position accounts for 1.18% of the portfolio, ranked #22.
Mirova first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $219M in Q4 2021. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Mirova held 63,957 shares of Thermo Fisher Scientific worth $32.1M as of Q2 2026.
- Mirova sold 9,318 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.47M.
- Thermo Fisher Scientific made up 1.18% of Mirova's portfolio in Q2 2026, its #22 holding.
- Mirova first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
- Mirova's Thermo Fisher Scientific position peaked at $219M in Q4 2021.
- 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Mirova's 13F filing for Q2 2026, filed 13 Aug 2026.